Below are the top mid-cap drug manufacturers-other stocks on the NYSE and the NASDAQ in terms of cash.
Forest Laboratories FRX had $2.12 billion in total cash and no debt for the latest quarter.
Cubist Pharmaceuticals CBST had $896.96 million in total cash for the latest quarter. However, Cubist Pharmaceuticals had $400.87 million in total debt for the same period.
United Therapeutics UTHR had $503.46 million in total cash and $273.37 million in total debt for the latest quarter.
Taro Pharmaceutical Industries TARO had $411.82 million in total cash and $37.65 million in total debt for the latest quarter.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in